Amgen (AMGN) EBT Margin (2009 - 2026)
Amgen (AMGN) posted quarterly EBT Margin of 24.18% for Q1 2026, down 3.0% year-over-year from 24.93% in Q1 2025, and up 57.58% quarter-over-quarter from 15.35% in Q4 2025.
Amgen (AMGN) EBT Margin (2009 - 2026) Analysis & Trends
Amgen's EBT Margin history runs 18 years deep, the most recent figure standing at 24.18% for Q1 2026.
- In Q1 2026, EBT Margin fell 3.0% year-over-year to 24.18%; the TTM figure through Mar 2026 stood at 24.41% (up 493.0% YoY), while the FY2025 annual figure was 24.42%, up 1063.0% from the prior year.
- EBT Margin for Q1 2026 stood at 24.18%, up from 15.35% in the prior quarter.
- The five-year high for EBT Margin was 380.83% in Q4 2022, with the low at 0.91% in Q1 2024.
- The 5-year median for EBT Margin is 24.18% (2026), against an average of 44.73%.
- The sharpest annual moves came in 2022 and 2023: EBT Margin soared 34970 bps in 2022, then plunged 37043 bps in 2023.
- Amgen's EBT Margin stood at 380.83% in 2022, then tumbled by 97 bps to 10.4% in 2023, then dropped by 17 bps to 8.61% in 2024, then surged by 78 bps to 15.35% in 2025, then soared by 58 bps to 24.18% in 2026.
- Business Quant data shows AMGN's EBT Margin at 24.18% in Q1 2026, 15.35% in Q4 2025, and 41.03% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | -4.34% |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 4.21% |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | 127.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 27.53% |
| Mar 31, 2026 | 24.18% |
| Dec 31, 2025 | 15.35% |
| Sep 30, 2025 | 41.03% |
| Jun 30, 2025 | 17.08% |
| Mar 31, 2025 | 24.21% |
| Dec 31, 2024 | 8.61% |
| Sep 30, 2024 | 36.47% |
| Jun 30, 2024 | 9.47% |
| Mar 31, 2024 | -0.91% |
| Dec 31, 2023 | 10.40% |
| Sep 30, 2023 | 28.21% |
| Jun 30, 2023 | 23.10% |
| Mar 31, 2023 | 56.38% |
| Dec 31, 2022 | 380.83% |
| Sep 30, 2022 | 35.96% |
| Jun 30, 2022 | 23.22% |
| Mar 31, 2022 | 26.85% |
| Dec 31, 2021 | 31.13% |
| Sep 30, 2021 | 32.14% |